18 earlier Form 4 trades (code P or S) here by this insider (18 sales), the last on Nov 12, 2024.
The trade is 2.1% of the 24,269 shares held after it.
1 other insider sold within 30 days.
367 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Gen. Counsel & Secretary TERRY ROBERT JOHN sold about $30.9K of SWKS on Nov 19, 2025, the largest insider sale at the company since 2024; 1 other insider sold within 30 days and 367 funds added in the latest 13F quarter.
18 earlier Form 4 trades (code P or S) here by this insider (18 sales), the last on Nov 12, 2024.
The trade is 22.4% of the 19,824 shares held after it.
1 other insider sold within 30 days.
367 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Gen. Counsel & Secretary TERRY ROBERT JOHN sold about $277.1K of SWKS on Nov 19, 2025, the largest insider sale at the company since 2024; 1 other insider sold within 30 days and 367 funds added in the latest 13F quarter.
9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Nov 11, 2024.
The trade is 2.1% of the 32,743 shares held after it.
1 other insider sold within 30 days.
367 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Chief Ops & Tech Officer Kasnavi Reza sold about $41.8K of SWKS on Nov 19, 2025, the largest insider sale at the company since 2024; 1 other insider sold within 30 days and 367 funds added in the latest 13F quarter.
9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Nov 11, 2024.
The trade is 25.5% of the 26,087 shares held after it.
1 other insider sold within 30 days.
367 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Chief Ops & Tech Officer Kasnavi Reza sold about $414.7K of SWKS on Nov 19, 2025, the largest insider sale at the company since 2024; 1 other insider sold within 30 days and 367 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SWKS planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
SWKS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
WBI Power Factor High Dividend ETF
$2.5M position · as of 2026-06-30
4.2%
Pzena U.S. Large Cap Value ETF
$2.5M position · as of 2026-05-31
4.0%
Pzena Mid Cap Value Fund
$3.9M position · as of 2026-05-31
3.8%
Global X Internet of Things ETF
$9.1M position · as of 2026-05-31
3.6%
Classic Value Fund
$17.9M position · as of 2026-07-31
3.3%
ProShares S&P Technology Dividend Aristocrats ETF
$9.1M position · as of 2026-05-31
3.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Liam K. Griffin
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$17.3M
$24.9M
$5.1M
-29%
+85%
2022
$16.7M
-$3.8M
$5.1M
-40%
-4%
2021
$16.2M
$17.7M
$4.2M
+13%
+36%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 367 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$4.0B
four quarters, 2025-06-28 to 2026-07-03
Revenue, TTM SWKS
FY Oct 2025
$4.1B
FY Sep 2024
$4.2B
FY Sep 2023
$4.8B
FY Sep 2022
$5.5B
FY Oct 2021
$5.1B
Jul 2026
$934.8M
Apr 2026
$943.7M
Jan 2026
$1.0B
Oct 2025
$1.1B
Jun 2025
$965.0M
Mar 2025
$953.2M
Dec 2024
$1.1B
Sep 2024
$1.0B
At each fiscal year end
Single quarter
Net margin, TTM
+7.2%
net income over revenue, 2025-06-28 to 2026-07-03
Net margin, TTM SWKS
FY Oct 2025
+11.7%
FY Sep 2024
+14.3%
FY Sep 2023
+20.6%
FY Sep 2022
+23.2%
FY Oct 2021
+29.3%
Jul 2026
+3.6%
Apr 2026
+3.8%
Jan 2026
+7.6%
Oct 2025
+12.9%
Jun 2025
+10.9%
Mar 2025
+7.2%
Dec 2024
+15.2%
Sep 2024
+5.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
$434.2M
operating cash flow minus capex, 2025-06-28 to 2026-07-03
Free cash flow, TTM SWKS
FY Oct 2025
$1.1B
FY Sep 2024
$1.7B
FY Sep 2023
$1.6B
FY Sep 2022
$935.2M
FY Oct 2021
$1.1B
Jul 2026
-$16.7M
Apr 2026
-$32.1M
Jan 2026
$339.0M
Oct 2025
$144.0M
Jun 2025
$252.7M
Mar 2025
$370.9M
Dec 2024
$338.2M
Sep 2024
$393.3M
At each fiscal year end
Single quarter
Debt to equity
0.09x
long-term 2026-07-03 plus current 2026-07-03; equity 2026-07-03
Debt to equity SWKS
FY Oct 2025
0.17x
FY Sep 2024
0.16x
FY Sep 2023
0.21x
FY Sep 2022
0.40x
FY Oct 2021
0.42x
Jul 2026
0.09x
Apr 2026
0.17x
Jan 2026
0.17x
Oct 2025
0.17x
Jun 2025
0.18x
Mar 2025
0.17x
Dec 2024
0.16x
Sep 2024
0.16x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.44x
TTM operating cash flow over long-term 2026-07-03 plus current 2026-07-03
Cash flow to debt SWKS
FY Oct 2025
1.31x
FY Sep 2024
1.84x
FY Sep 2023
1.44x
FY Sep 2022
0.65x
FY Oct 2021
0.79x
Jul 2026
1.44x
Apr 2026
0.96x
Jan 2026
1.32x
Oct 2025
1.31x
Jun 2025
1.58x
Mar 2025
1.54x
Dec 2024
1.43x
Sep 2024
1.84x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+5.1%
TTM net income over average of 2025-06-27 and 2026-07-03
Return on equity SWKS
FY Oct 2025
+7.9%
FY Sep 2024
+9.6%
FY Sep 2023
+17.0%
FY Sep 2022
+23.7%
FY Oct 2021
+31.7%
Jul 2026
+5.1%
Apr 2026
+6.2%
Jan 2026
+6.5%
Oct 2025
+7.9%
Jun 2025
+6.6%
Mar 2025
+6.7%
Dec 2024
+8.3%
Sep 2024
+9.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+3.8%
TTM net income over average of 2025-06-27 and 2026-07-03
Return on assets SWKS
FY Oct 2025
+5.9%
FY Sep 2024
+7.1%
FY Sep 2023
+11.4%
FY Sep 2022
+14.6%
FY Oct 2021
+21.9%
Jul 2026
+3.8%
Apr 2026
+4.6%
Jan 2026
+4.9%
Oct 2025
+5.9%
Jun 2025
+5.0%
Mar 2025
+5.1%
Dec 2024
+6.4%
Sep 2024
+7.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+5.2%
operating income after a 11.0% effective tax rate, over long-term 2026-07-03 plus current 2026-07-03 plus average of 2025-06-27 and 2026-07-03 minus cash
Return on invested capital SWKS
FY Oct 2025
+7.8%
FY Sep 2024
+9.7%
FY Sep 2023
+15.9%
FY Sep 2022
+19.3%
FY Oct 2021
+24.2%
Jul 2026
+5.2%
Apr 2026
+6.3%
Jan 2026
+6.8%
Oct 2025
+7.8%
Jun 2025
+6.7%
Mar 2025
+6.8%
Dec 2024
+8.6%
Sep 2024
+9.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+4.7%
operating income (EBIT proxy) over average of 2025-06-27 and 2026-07-03 minus current liabilities
Return on capital employed SWKS
FY Oct 2025
+7.0%
FY Sep 2024
+8.4%
FY Sep 2023
+14.9%
FY Sep 2022
+19.6%
FY Oct 2021
+25.6%
Jul 2026
+4.7%
Apr 2026
+5.3%
Jan 2026
+5.9%
Oct 2025
+7.0%
Jun 2025
+6.3%
Mar 2025
+6.3%
Dec 2024
+7.3%
Sep 2024
+8.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
43.18x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-28 to 2026-07-03
P/E, trailing SWKS
FY Oct 2025
25.11x
FY Sep 2024
26.72x
FY Sep 2023
16.08x
FY Sep 2022
10.93x
FY Oct 2021
18.27x
Jul 2026
32.41x
Apr 2026
22.90x
Jan 2026
24.77x
Oct 2025
25.11x
Jun 2025
29.92x
Mar 2025
25.15x
Dec 2024
27.65x
Sep 2024
26.72x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$12.2B
market value at close 2026-10-26 on 2026-07-23 shares, plus long-term 2026-07-03 plus current 2026-07-03, minus cash 2026-07-03
Enterprise value SWKS
FY Oct 2025
$11.3B
FY Sep 2024
$15.4B
FY Sep 2023
$16.3B
FY Sep 2022
$15.3B
FY Oct 2021
$28.4B
Jul 2026
$9.1B
Apr 2026
$7.9B
Jan 2026
$9.0B
Oct 2025
$11.3B
Jun 2025
$11.0B
Mar 2025
$9.9B
Dec 2024
$13.8B
Sep 2024
$15.4B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.5%
TTM free cash flow over market value at close 2026-10-26
FCF yield SWKS
FY Oct 2025
+9.7%
FY Sep 2024
+10.6%
FY Sep 2023
+10.5%
FY Sep 2022
+6.8%
FY Oct 2021
+4.2%
Jul 2026
+4.6%
Apr 2026
+8.5%
Jan 2026
+11.6%
Oct 2025
+9.7%
Jun 2025
+12.1%
Mar 2025
+13.1%
Dec 2024
+8.7%
Sep 2024
+10.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -23%, PEG needs growth
PEG, trailing SWKS
FY Oct 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Oct 2021
0.21x
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SWKS ranks highest on financial health (75th percentile) and institutional and government (53rd), and lowest on risk and compliance (9th), among Semiconductors & Electronics peers.
Profitability
46
Inputs
Return on equity+5.1% · 55 pct, sector of 154
Return on assets+3.8% · 61 pct, sector of 171
Return on invested capital+5.2% · 15 pct, sector of 56
Return on capital employed+4.7% · 55 pct, sector of 155
Financial health
75
Inputs
Debt to equity0.09x · 66 pct, sector of 152
Cash flow to debt1.44x · 84 pct, sector of 136
Growth
27
Inputs
Revenue growth, YoY-2.2% · 27 pct, sector of 194
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
53
Inputs
Funds adding, latest quarter367 · 81 pct, sector of 184
Congress net buyers, 365d0 · 26 pct, sector of 40
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
9
Inputs
Short interest, % of float+18.6% · 10 pct, sector of 221
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+30.0% · 7 pct, sector of 152
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SWKS filings, in plain words
Have members of Congress traded SWKS?
Yes. In the year to 2026-10-27, 1 House member disclosed buying SWKS and 1 House member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-02-10.
Read the full summary
In the year to 2026-10-27, 1 member of Congress disclosed buying SWKS and 1 member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-02-10. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.